WASHINGTON: US biotech company Novavax Inc was granted full marketing authorisation on Thursday by the European Commission for the use of the coronavirus vaccine Nuvaxovid in the European Union, the company said, reported German news agency (dpa). The decision follows a positive opinion for a full marketing authorisation from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA).The vaccine is now fully authorised for use as a primary series in individuals, aged 12 and older, and as a booster dose in adults, aged 18 and older, for the prevention of Covid-19. Nuvaxovid was originally granted a conditional marketing authorisation in the EU for these indicat
Hence then, the article about novavax s nuvaxovid covid 19 vaccine gets marketing authorisation for eu was published today ( ) and is available onDaily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Novavax’s Nuvaxovid Covid-19 vaccine gets marketing authorisation for EU )